MiR-199a attenuates endometrial stromal cell invasiveness through suppression of the IKKβ/NF-κB pathway and reduced interleukin-8 expression
MicroRNAs have recently been identified as regulators that modulate target gene expression and are suggested to be involved in the development and progression of endometriosis. This study was undertaken to analyze the expression level of microRNA-199a (miR-199a) in paired ovarian endometrioma and eu...
Saved in:
Published in | Molecular human reproduction Vol. 18; no. 3; pp. 136 - 145 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
England
Oxford University Press
01.03.2012
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | MicroRNAs have recently been identified as regulators that modulate target gene expression and are suggested to be involved in the development and progression of endometriosis. This study was undertaken to analyze the expression level of microRNA-199a (miR-199a) in paired ovarian endometrioma and eutopic endometrium from women with endometriosis, and to investigate the contribution of miR-199a to the invasive capability of endometrial stromal cells (ESCs). Cell adhesion, migration and Matrigel invasion assays were carried out to measure the invasiveness of ESCs. Bioinformatics prediction, reporter gene assay, PCR, western blotting and ELISA were performed to identify miR-199a targets and related signaling pathways. The results showed that the expression level of miR-199a was lower in the eutopic endometrium from women with endometriosis, and even lower in the paired ovarian endometrioma, compared with the expression in normal controls. Moreover, ectopic expression of miR-199a attenuated ESC adhesion, migration and invasiveness. MiR-199a targeted and inhibited IkappaB kinase beta (IKKβ) in ESCs. Accompanied by IKKβ reduction, miR-199a suppressed nuclear factor-kappa B (NF-κB) pathway activation and interleukin-8 (IL-8) production in ESCs. All these findings suggest that miR-199a, down-regulated in endometriosis, attenuates the invasive capability of ESCs in vitro partly through IKK/NF-κB pathway suppression and reduced IL-8 expression. In conclusion, miR-199a could be involved in the pathogenesis of endometriosis. |
---|---|
AbstractList | MicroRNAs have recently been identified as regulators that modulate target gene expression and are suggested to be involved in the development and progression of endometriosis. This study was undertaken to analyze the expression level of microRNA-199a (miR-199a) in paired ovarian endometrioma and eutopic endometrium from women with endometriosis, and to investigate the contribution of miR-199a to the invasive capability of endometrial stromal cells (ESCs). Cell adhesion, migration and Matrigel invasion assays were carried out to measure the invasiveness of ESCs. Bioinformatics prediction, reporter gene assay, PCR, western blotting and ELISA were performed to identify miR-199a targets and related signaling pathways. The results showed that the expression level of miR-199a was lower in the eutopic endometrium from women with endometriosis, and even lower in the paired ovarian endometrioma, compared with the expression in normal controls. Moreover, ectopic expression of miR-199a attenuated ESC adhesion, migration and invasiveness. MiR-199a targeted and inhibited IkappaB kinase beta (IKKβ) in ESCs. Accompanied by IKKβ reduction, miR-199a suppressed nuclear factor-kappa B (NF-κB) pathway activation and interleukin-8 (IL-8) production in ESCs. All these findings suggest that miR-199a, down-regulated in endometriosis, attenuates the invasive capability of ESCs in vitro partly through IKK/NF-κB pathway suppression and reduced IL-8 expression. In conclusion, miR-199a could be involved in the pathogenesis of endometriosis. MicroRNAs have recently been identified as regulators that modulate target gene expression and are suggested to be involved in the development and progression of endometriosis. This study was undertaken to analyze the expression level of microRNA-199a (miR-199a) in paired ovarian endometrioma and eutopic endometrium from women with endometriosis, and to investigate the contribution of miR-199a to the invasive capability of endometrial stromal cells (ESCs). Cell adhesion, migration and Matrigel invasion assays were carried out to measure the invasiveness of ESCs. Bioinformatics prediction, reporter gene assay, PCR, western blotting and ELISA were performed to identify miR-199a targets and related signaling pathways. The results showed that the expression level of miR-199a was lower in the eutopic endometrium from women with endometriosis, and even lower in the paired ovarian endometrioma, compared with the expression in normal controls. Moreover, ectopic expression of miR-199a attenuated ESC adhesion, migration and invasiveness. MiR-199a targeted and inhibited IkappaB kinase beta (IKKβ) in ESCs. Accompanied by IKKβ reduction, miR-199a suppressed nuclear factor-kappa B (NF-κB) pathway activation and interleukin-8 (IL-8) production in ESCs. All these findings suggest that miR-199a, down-regulated in endometriosis, attenuates the invasive capability of ESCs in vitro partly through IKK/NF-κB pathway suppression and reduced IL-8 expression. In conclusion, miR-199a could be involved in the pathogenesis of endometriosis.MicroRNAs have recently been identified as regulators that modulate target gene expression and are suggested to be involved in the development and progression of endometriosis. This study was undertaken to analyze the expression level of microRNA-199a (miR-199a) in paired ovarian endometrioma and eutopic endometrium from women with endometriosis, and to investigate the contribution of miR-199a to the invasive capability of endometrial stromal cells (ESCs). Cell adhesion, migration and Matrigel invasion assays were carried out to measure the invasiveness of ESCs. Bioinformatics prediction, reporter gene assay, PCR, western blotting and ELISA were performed to identify miR-199a targets and related signaling pathways. The results showed that the expression level of miR-199a was lower in the eutopic endometrium from women with endometriosis, and even lower in the paired ovarian endometrioma, compared with the expression in normal controls. Moreover, ectopic expression of miR-199a attenuated ESC adhesion, migration and invasiveness. MiR-199a targeted and inhibited IkappaB kinase beta (IKKβ) in ESCs. Accompanied by IKKβ reduction, miR-199a suppressed nuclear factor-kappa B (NF-κB) pathway activation and interleukin-8 (IL-8) production in ESCs. All these findings suggest that miR-199a, down-regulated in endometriosis, attenuates the invasive capability of ESCs in vitro partly through IKK/NF-κB pathway suppression and reduced IL-8 expression. In conclusion, miR-199a could be involved in the pathogenesis of endometriosis. MicroRNAs have recently been identified as regulators that modulate target gene expression and are suggested to be involved in the development and progression of endometriosis. This study was undertaken to analyze the expression level of microRNA-199a (miR-199a) in paired ovarian endometrioma and eutopic endometrium from women with endometriosis, and to investigate the contribution of miR-199a to the invasive capability of endometrial stromal cells (ESCs). Cell adhesion, migration and Matrigel invasion assays were carried out to measure the invasiveness of ESCs. Bioinformatics prediction, reporter gene assay, PCR, western blotting and ELISA were performed to identify miR-199a targets and related signaling pathways. The results showed that the expression level of miR-199a was lower in the eutopic endometrium from women with endometriosis, and even lower in the paired ovarian endometrioma, compared with the expression in normal controls. Moreover, ectopic expression of miR-199a attenuated ESC adhesion, migration and invasiveness. MiR-199a targeted and inhibited IkappaB kinase beta (IKKβ) in ESCs. Accompanied by IKKβ reduction, miR-199a suppressed nuclear factor-kappa B (NF-κB) pathway activation and interleukin-8 (IL-8) production in ESCs. All these findings suggest that miR-199a, down-regulated in endometriosis, attenuates the invasive capability of ESCs in vitro partly through IKK/NF-κB pathway suppression and reduced IL-8 expression. In conclusion, miR-199a could be involved in the pathogenesis of endometriosis. |
Author | Gu, Liying Dai, Lan Di, Wen |
AuthorAffiliation | 2 Shanghai Key Laboratory of Gynecologic Oncology , Focus Construction Subject of Shanghai Education Department , Shanghai , People's Republic of China 1 Department of Obstetrics and Gynecology , Renji Hospital, Shanghai Jiaotong University School of Medicine , 1630 Dong Fang Rd., Shanghai 200127, People's Republic of China |
AuthorAffiliation_xml | – name: 1 Department of Obstetrics and Gynecology , Renji Hospital, Shanghai Jiaotong University School of Medicine , 1630 Dong Fang Rd., Shanghai 200127, People's Republic of China – name: 2 Shanghai Key Laboratory of Gynecologic Oncology , Focus Construction Subject of Shanghai Education Department , Shanghai , People's Republic of China |
Author_xml | – sequence: 1 givenname: Lan surname: Dai fullname: Dai, Lan organization: Department of Obstetrics and Gynecology, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200127, People's Republic of China – sequence: 2 givenname: Liying surname: Gu fullname: Gu, Liying – sequence: 3 givenname: Wen surname: Di fullname: Di, Wen |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/21989168$$D View this record in MEDLINE/PubMed |
BookMark | eNpVkc1u1TAQhS3Uiv7QJVvkHatwbcfXsTdIUFGo2lKpoutoEk9uDIkdbOdCX4KHYclD9JlI1RaV1RmdOfqONHNAdnzwSMhLzt5wZsrVGAbs42oDkSn1jOxzqVghJKt2nsx75CClr4zxSqz1c7InuNGGK71Pfl24q4IbAxRyRj9DxkTR2zBijg4GmnIM46ItDgN1fgvJbdFjSjT3McybnqZ5muJiuOBp6BYb6enZ2e3v1eeT4vbPezpB7n_ADQVvaUQ7t2gXUMY44PzN-UJT_PkIeEF2OxgSHj3oIbk--fDl-FNxfvnx9PjdeTFxzXIh0AreVqpTGkrdQScaYZhWsmkqpo2QHdcWJLeVKi22FbPCNEaAkYILubblIXl7z53mZkTbos8RhnqKboR4Uwdw9f8b7_p6E7Z1KYwozXoBvH4AxPB9xpTr0aW7G4HHMKd6Sa0rxaVckq-eVv3rePxB-RdN_5DT |
ContentType | Journal Article |
Copyright | The Author 2011. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. All rights reserved. For Permissions, please email: journals.permissions@oup.com 2011 |
Copyright_xml | – notice: The Author 2011. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. All rights reserved. For Permissions, please email: journals.permissions@oup.com 2011 |
DBID | CGR CUY CVF ECM EIF NPM 7X8 5PM |
DOI | 10.1093/molehr/gar066 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Anatomy & Physiology |
EISSN | 1460-2407 |
EndPage | 145 |
ExternalDocumentID | PMC3292395 21989168 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- -E4 .2P .GJ .I3 0R~ 123 18M 29M 2WC 4.4 482 48X 53G 5WA 5WD 70D AABZA AACZT AAIMJ AAJKP AAJQQ AAMVS AAOGV AAPGJ AAPNW AAPQZ AAPXW AARHZ AAUAY AAUQX AAVAP AAVLN AAWDT ABDFA ABEJV ABEUO ABGNP ABIME ABIXL ABJNI ABKDP ABMNT ABNGD ABNHQ ABNKS ABPIB ABPQP ABPTD ABQLI ABQTQ ABSMQ ABVGC ABWST ABXVV ABXZS ABZBJ ABZEO ACFRR ACGFO ACGFS ACPQN ACPRK ACUFI ACUKT ACUTJ ACUTO ACVCV ACZBC ADEYI ADEZT ADFTL ADGKP ADGZP ADHKW ADHZD ADIPN ADMTO ADNBA ADOCK ADQBN ADRTK ADVEK ADYVW ADZTZ AEGPL AEHUL AEJOX AEKPW AEKSI AELWJ AEMDU AENEX AENZO AEPUE AETBJ AEWNT AFFQV AFFZL AFGWE AFIYH AFOFC AFSHK AFYAG AGINJ AGKEF AGKRT AGMDO AGQXC AGSYK AHMBA AHMMS AHXPO AIAGR AIJHB AJDVS AJEEA AJNCP AKHUL ALMA_UNASSIGNED_HOLDINGS ALUQC ALXQX ANFBD APIBT APJGH APWMN AQDSO AQKUS ARIXL ASAOO ATDFG ATGXG ATTQO AVNTJ BAYMD BCRHZ BEYMZ BQDIO BSWAC BTRTY BVRKM BZKNY CAG CDBKE CGR COF CS3 CUY CVF CXTWN CZ4 DAKXR DFGAJ DIK DILTD DU5 D~K E3Z EBD EBS ECM EE~ EIF EIHJH EJD ELUNK EMOBN F5P F9B FEDTE FHSFR FLUFQ FOEOM FOTVD FQBLK GAUVT GJXCC GX1 H13 H5~ HAR HH5 HVGLF HW0 HZ~ IOX J21 JXSIZ KAQDR KOP KQ8 KSI KSN M-Z M49 MBLQV MBTAY N9A NGC NLBLG NOMLY NOYVH NPM NTWIH NU- NVLIB O0~ O9- OAWHX OBFPC OBOKY OCZFY ODMLO OJQWA OJZSN OK1 OPAEJ OVD OWPYF O~Y P2P PAFKI PB- PEELM PQQKQ Q1. Q5Y QBD R44 RD5 RIG RNI ROL ROX ROZ RUSNO RW1 RXO RZF RZO SV3 TCN TEORI TJX TLC TMA TR2 W8F WOQ X7H YAYTL YKOAZ YXANX ZKX ~91 ~S- 7X8 AGORE AJBYB 5PM |
ID | FETCH-LOGICAL-p180t-2ed21c76f68a38faf2b290864bb708924f18da41d763dec70d29b92a9421245d3 |
ISSN | 1460-2407 1360-9947 |
IngestDate | Thu Aug 21 14:30:07 EDT 2025 Fri Jul 11 05:20:07 EDT 2025 Thu Apr 03 07:07:47 EDT 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-p180t-2ed21c76f68a38faf2b290864bb708924f18da41d763dec70d29b92a9421245d3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Lan Dai and Liying Gu contributed equally to this work. |
PMID | 21989168 |
PQID | 923576144 |
PQPubID | 23479 |
PageCount | 10 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_3292395 proquest_miscellaneous_923576144 pubmed_primary_21989168 |
PublicationCentury | 2000 |
PublicationDate | 2012-03-00 |
PublicationDateYYYYMMDD | 2012-03-01 |
PublicationDate_xml | – month: 03 year: 2012 text: 2012-03-00 |
PublicationDecade | 2010 |
PublicationPlace | England |
PublicationPlace_xml | – name: England |
PublicationTitle | Molecular human reproduction |
PublicationTitleAlternate | Mol Hum Reprod |
PublicationYear | 2012 |
Publisher | Oxford University Press |
Publisher_xml | – name: Oxford University Press |
References | 18632614 - Cancer Res. 2008 Jul 15;68(14):5619-27 18408758 - Oncogene. 2008 Aug 7;27(34):4712-23 18710704 - Fertil Steril. 2009 May;91(5 Suppl):2148-56 12554859 - RNA. 2003 Feb;9(2):175-9 19683430 - Eur J Cancer. 2009 Sep;45(14):2618-27 12624257 - Science. 2003 Mar 7;299(5612):1540 17483545 - Mol Hum Reprod. 2007 Jul;13(7):503-9 17028437 - Gynecol Obstet Invest. 2007;63(2):71-97 20188363 - Fertil Steril. 2010 Nov;94(6):1985-94 19589872 - Endocrinology. 2009 Oct;150(10):4734-43 21436242 - Chest. 2011 Oct;140(4):980-90 20300586 - J Biomed Biotechnol. 2010;2010:369549 20400975 - Oncogene. 2010 Jun 17;29(24):3545-53 21268001 - Eur J Immunol. 2011 Feb;41(2):306-12 19446316 - Gynecol Oncol. 2009 Aug;114(2):253-9 19010917 - Cancer Res. 2008 Nov 15;68(22):9423-32 17575287 - Hum Reprod Update. 2007 Sep-Oct;13(5):487-99 19773286 - Hum Reprod Update. 2010 Mar-Apr;16(2):142-65 21030494 - Mol Hum Reprod. 2011 Mar;17(3):175-81 18791135 - J Anim Sci. 2009 Apr;87(14 Suppl):E29-38 20561612 - Fertil Steril. 2010 Dec;94(7):2942-4 18314120 - Fertil Steril. 2009 Mar;91(3):687-93 21436257 - Mol Endocrinol. 2011 May;25(5):821-32 21383689 - Oncogene. 2011 Aug 4;30(31):3404-15 20624982 - Proc Natl Acad Sci U S A. 2010 Jul 27;107(30):13450-5 10453354 - Endocr Rev. 1999 Aug;20(4):435-59 10499541 - Endocrinology. 1999 Oct;140(10):4809-20 18684450 - Fertil Steril. 2009 May;91(5 Suppl):2185-92 18941111 - Blood. 2009 Jan 8;113(2):396-402 17766684 - Mol Hum Reprod. 2007 Nov;13(11):797-806 10439007 - Fertil Steril. 1999 Aug;72(2):336-40 19088369 - Reprod Sci. 2008 Dec;15(10):993-1001 20103651 - Cancer Res. 2010 Feb 1;70(3):1063-71 21292970 - Science. 2011 Feb 4;331(6017):550-3 19892605 - J Minim Invasive Gynecol. 2010 Jan-Feb;17(1):21-5 7962366 - Hum Reprod. 1994 Jun;9(6):1001-2 19651637 - Mol Hum Reprod. 2009 Oct;15(10):587-607 12496258 - J Biol Chem. 2003 Mar 7;278(10):8508-15 18688027 - Am J Pathol. 2008 Sep;173(3):700-15 18560586 - PLoS One. 2008;3(6):e2436 21266580 - J Biol Chem. 2011 Mar 25;286(12):10483-94 15690968 - Wien Klin Wochenschr. 2004 Dec 30;116(24):839-43 9543141 - J Clin Endocrinol Metab. 1998 Apr;83(4):1201-5 10087424 - Gynecol Obstet Invest. 1999;47 Suppl 1:18-20; discussion 20-2 17175059 - Lung Cancer. 2007 Apr;56(1):25-33 15541453 - Lancet. 2004 Nov 13-19;364(9447):1789-99 19692421 - Mol Hum Reprod. 2009 Oct;15(10):625-31 19398263 - Cancer Lett. 2009 Oct 8;283(2):159-67 20573927 - N Engl J Med. 2010 Jun 24;362(25):2389-98 21245828 - Nat Rev Genet. 2011 Feb;12(2):99-110 10488062 - J Biol Chem. 1999 Sep 24;274(39):27339-42 20799954 - Mol Cancer. 2010;9:227 20627991 - Mol Hum Reprod. 2010 Nov;16(11):818-34 14708018 - Nat Rev Drug Discov. 2004 Jan;3(1):17-26 21048306 - Biol Pharm Bull. 2010;33(11):1822-7 18451233 - Clin Cancer Res. 2008 May 1;14(9):2690-5 20424119 - Cancer Res. 2010 May 15;70(10):4005-14 19074548 - Mol Endocrinol. 2009 Feb;23(2):265-75 15019828 - Fertil Steril. 2004 Mar;81 Suppl 1:904-11 21335415 - Hum Reprod. 2011 May;26(5):1082-90 |
References_xml | – reference: 18684450 - Fertil Steril. 2009 May;91(5 Suppl):2185-92 – reference: 21268001 - Eur J Immunol. 2011 Feb;41(2):306-12 – reference: 21436257 - Mol Endocrinol. 2011 May;25(5):821-32 – reference: 15690968 - Wien Klin Wochenschr. 2004 Dec 30;116(24):839-43 – reference: 20624982 - Proc Natl Acad Sci U S A. 2010 Jul 27;107(30):13450-5 – reference: 20400975 - Oncogene. 2010 Jun 17;29(24):3545-53 – reference: 20188363 - Fertil Steril. 2010 Nov;94(6):1985-94 – reference: 21436242 - Chest. 2011 Oct;140(4):980-90 – reference: 10453354 - Endocr Rev. 1999 Aug;20(4):435-59 – reference: 14708018 - Nat Rev Drug Discov. 2004 Jan;3(1):17-26 – reference: 10488062 - J Biol Chem. 1999 Sep 24;274(39):27339-42 – reference: 18632614 - Cancer Res. 2008 Jul 15;68(14):5619-27 – reference: 20300586 - J Biomed Biotechnol. 2010;2010:369549 – reference: 20561612 - Fertil Steril. 2010 Dec;94(7):2942-4 – reference: 18791135 - J Anim Sci. 2009 Apr;87(14 Suppl):E29-38 – reference: 12624257 - Science. 2003 Mar 7;299(5612):1540 – reference: 20573927 - N Engl J Med. 2010 Jun 24;362(25):2389-98 – reference: 18408758 - Oncogene. 2008 Aug 7;27(34):4712-23 – reference: 21245828 - Nat Rev Genet. 2011 Feb;12(2):99-110 – reference: 19892605 - J Minim Invasive Gynecol. 2010 Jan-Feb;17(1):21-5 – reference: 19088369 - Reprod Sci. 2008 Dec;15(10):993-1001 – reference: 10439007 - Fertil Steril. 1999 Aug;72(2):336-40 – reference: 19010917 - Cancer Res. 2008 Nov 15;68(22):9423-32 – reference: 21335415 - Hum Reprod. 2011 May;26(5):1082-90 – reference: 19773286 - Hum Reprod Update. 2010 Mar-Apr;16(2):142-65 – reference: 21048306 - Biol Pharm Bull. 2010;33(11):1822-7 – reference: 17028437 - Gynecol Obstet Invest. 2007;63(2):71-97 – reference: 20424119 - Cancer Res. 2010 May 15;70(10):4005-14 – reference: 18688027 - Am J Pathol. 2008 Sep;173(3):700-15 – reference: 20627991 - Mol Hum Reprod. 2010 Nov;16(11):818-34 – reference: 17766684 - Mol Hum Reprod. 2007 Nov;13(11):797-806 – reference: 21030494 - Mol Hum Reprod. 2011 Mar;17(3):175-81 – reference: 21383689 - Oncogene. 2011 Aug 4;30(31):3404-15 – reference: 17483545 - Mol Hum Reprod. 2007 Jul;13(7):503-9 – reference: 19074548 - Mol Endocrinol. 2009 Feb;23(2):265-75 – reference: 19589872 - Endocrinology. 2009 Oct;150(10):4734-43 – reference: 12554859 - RNA. 2003 Feb;9(2):175-9 – reference: 20799954 - Mol Cancer. 2010;9:227 – reference: 21292970 - Science. 2011 Feb 4;331(6017):550-3 – reference: 9543141 - J Clin Endocrinol Metab. 1998 Apr;83(4):1201-5 – reference: 15541453 - Lancet. 2004 Nov 13-19;364(9447):1789-99 – reference: 18451233 - Clin Cancer Res. 2008 May 1;14(9):2690-5 – reference: 18941111 - Blood. 2009 Jan 8;113(2):396-402 – reference: 10087424 - Gynecol Obstet Invest. 1999;47 Suppl 1:18-20; discussion 20-2 – reference: 19651637 - Mol Hum Reprod. 2009 Oct;15(10):587-607 – reference: 18314120 - Fertil Steril. 2009 Mar;91(3):687-93 – reference: 7962366 - Hum Reprod. 1994 Jun;9(6):1001-2 – reference: 19692421 - Mol Hum Reprod. 2009 Oct;15(10):625-31 – reference: 12496258 - J Biol Chem. 2003 Mar 7;278(10):8508-15 – reference: 10499541 - Endocrinology. 1999 Oct;140(10):4809-20 – reference: 18710704 - Fertil Steril. 2009 May;91(5 Suppl):2148-56 – reference: 21266580 - J Biol Chem. 2011 Mar 25;286(12):10483-94 – reference: 19398263 - Cancer Lett. 2009 Oct 8;283(2):159-67 – reference: 18560586 - PLoS One. 2008;3(6):e2436 – reference: 19446316 - Gynecol Oncol. 2009 Aug;114(2):253-9 – reference: 17575287 - Hum Reprod Update. 2007 Sep-Oct;13(5):487-99 – reference: 15019828 - Fertil Steril. 2004 Mar;81 Suppl 1:904-11 – reference: 19683430 - Eur J Cancer. 2009 Sep;45(14):2618-27 – reference: 17175059 - Lung Cancer. 2007 Apr;56(1):25-33 – reference: 20103651 - Cancer Res. 2010 Feb 1;70(3):1063-71 |
SSID | ssj0017258 |
Score | 2.3437822 |
Snippet | MicroRNAs have recently been identified as regulators that modulate target gene expression and are suggested to be involved in the development and progression... |
SourceID | pubmedcentral proquest pubmed |
SourceType | Open Access Repository Aggregation Database Index Database |
StartPage | 136 |
SubjectTerms | Adult Blotting, Western Cell Adhesion - genetics Cell Adhesion - physiology Cell Movement - genetics Cell Movement - physiology Cells, Cultured Endometriosis - metabolism Endometrium - cytology Enzyme-Linked Immunosorbent Assay Female Humans I-kappa B Kinase - metabolism In Vitro Techniques Interleukin-8 - genetics Interleukin-8 - metabolism MicroRNAs - genetics MicroRNAs - metabolism NF-kappa B - metabolism Real-Time Polymerase Chain Reaction Signal Transduction - genetics Signal Transduction - physiology Stromal Cells - cytology Stromal Cells - metabolism Young Adult |
Title | MiR-199a attenuates endometrial stromal cell invasiveness through suppression of the IKKβ/NF-κB pathway and reduced interleukin-8 expression |
URI | https://www.ncbi.nlm.nih.gov/pubmed/21989168 https://www.proquest.com/docview/923576144 https://pubmed.ncbi.nlm.nih.gov/PMC3292395 |
Volume | 18 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NbhMxELZCuXBBlPITKMgHyqXaZv93fUxCS0uUCqFW9BZ5194mgnijZBdUHoKH4Yh4hj4T459NnBIk6GW1mji2vPPt2OOd-QahVwkNvZQXmUPjMHPCKM8dGhTwXiUpAIrlxFUZcsPT-Pg8fHcRXbRav6yopbrKDvJvG_NKbqNVkIFeZZbsf2h22SkI4B70C1fQMFz_ScfDyQcZwkH3JUmmqOW2cZ8LVk65LsaxqOblVBKAyAO6ifhCF41ta8rzLOqZiYQVTbTAyWCw1z_c60nK1NMjR913e5KAdfyVaramueR75UxxTcw_8_rTRDipLBZgurJ3vMOm_q4pByhZNBXJrBUA8IaaHO2l5G2tDwyumpVVtlKNPprcNXNSIUM-Avuk4i8ZkJbxDWLXIUQzcB5wLQtBJr3OzRZ75dAr8-sFsbWSe5qo8o9FQhNoTWH6Y0nRcknnrq78YkFmNlWY8WVImacL_9zg5X4_7Ac-bI9JdAfd9cFJUQ79yWD5DSvxVXXY5awMwyuM3tFjd_TIio9aD7PJzbkZrWttf84eoPvGb8FdDcJt1OLiIdrpClqV0yv8GqtIYvWJZgd9b3CJV7jEFi6xwSWWuMQ2LrHBJbZwicsCxBwDLq9_dACR1z972KARAxqxQSNeQyNeofEROj86POsfO6buhzPzUrdyfM58L0_iIk5pkBa08DOfgOsdZlnipsQPCy9lYGMYrI2M54nLfJIRnxIZ3RBGLHiMtkQp-FOE3SSPmcsSL-EMQFRkUZQSRqGbLM3jPGkj3DzwEdhVOW0qeFkvRkTyQMnTkjZ6op__aKb5X0aNttooWdPMsoGkbF__RUzGirrdIObZrf_5HN1bvVq7aKua1_wFbIur7KVC329uW8Nx |
linkProvider | Flying Publisher |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=MiR-199a+attenuates+endometrial+stromal+cell+invasiveness+through+suppression+of+the+IKK%CE%B2%2FNF-%CE%BAB+pathway+and+reduced+interleukin-8+expression&rft.jtitle=Molecular+human+reproduction&rft.au=Dai%2C+Lan&rft.au=Gu%2C+Liying&rft.au=Di%2C+Wen&rft.date=2012-03-01&rft.pub=Oxford+University+Press&rft.issn=1360-9947&rft.eissn=1460-2407&rft.volume=18&rft.issue=3&rft.spage=136&rft.epage=145&rft_id=info:doi/10.1093%2Fmolehr%2Fgar066&rft_id=info%3Apmid%2F21989168&rft.externalDocID=PMC3292395 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1460-2407&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1460-2407&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1460-2407&client=summon |